These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 30789747)

  • 1. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
    O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP
    Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
    Molyneaux PL; Cox MJ; Willis-Owen SA; Mallia P; Russell KE; Russell AM; Murphy E; Johnston SL; Schwartz DA; Wells AU; Cookson WO; Maher TM; Moffatt MF
    Am J Respir Crit Care Med; 2014 Oct; 190(8):906-13. PubMed ID: 25184687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study.
    Valenzi E; Yang H; Sembrat JC; Yang L; Winters S; Nettles R; Kass DJ; Qin S; Wang X; Myerburg MM; Methé B; Fitch A; Alder JK; Benos PV; McVerry BJ; Rojas M; Morris A; Kitsios GD
    Thorax; 2021 Mar; 76(3):239-247. PubMed ID: 33268457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
    Molyneaux PL; Cox MJ; Wells AU; Kim HC; Ji W; Cookson WO; Moffatt MF; Kim DS; Maher TM
    Respir Res; 2017 Feb; 18(1):29. PubMed ID: 28143484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis.
    Takahashi Y; Saito A; Chiba H; Kuronuma K; Ikeda K; Kobayashi T; Ariki S; Takahashi M; Sasaki Y; Takahashi H
    Respir Res; 2018 Feb; 19(1):34. PubMed ID: 29486761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.
    Molyneaux PL; Willis-Owen SAG; Cox MJ; James P; Cowman S; Loebinger M; Blanchard A; Edwards LM; Stock C; Daccord C; Renzoni EA; Wells AU; Moffatt MF; Cookson WOC; Maher TM
    Am J Respir Crit Care Med; 2017 Jun; 195(12):1640-1650. PubMed ID: 28085486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.
    Fastrès A; Felice F; Roels E; Moermans C; Corhay JL; Bureau F; Louis R; Clercx C; Guiot J
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis.
    Invernizzi R; Molyneaux PL
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
    Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
    PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis.
    Invernizzi R; Wu BG; Barnett J; Ghai P; Kingston S; Hewitt RJ; Feary J; Li Y; Chua F; Wu Z; Wells AU; George PM; Renzoni EA; Nicholson AG; Rice A; Devaraj A; Segal LN; Byrne AJ; Maher TM; Lloyd CM; Molyneaux PL
    Am J Respir Crit Care Med; 2021 Feb; 203(3):339-347. PubMed ID: 32692582
    [No Abstract]   [Full Text] [Related]  

  • 11. Dysregulated Lung Commensal Bacteria Drive Interleukin-17B Production to Promote Pulmonary Fibrosis through Their Outer Membrane Vesicles.
    Yang D; Chen X; Wang J; Lou Q; Lou Y; Li L; Wang H; Chen J; Wu M; Song X; Qian Y
    Immunity; 2019 Mar; 50(3):692-706.e7. PubMed ID: 30824326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung Dysbiosis, Inflammation, and Injury in Hematopoietic Cell Transplantation.
    O'Dwyer DN; Zhou X; Wilke CA; Xia M; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Murray S; Erb-Downward JR; Yanik GA; Moore BB; Dickson RP
    Am J Respir Crit Care Med; 2018 Nov; 198(10):1312-1321. PubMed ID: 29878854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis.
    Spagnolo P; Molyneaux PL; Bernardinello N; Cocconcelli E; Biondini D; Fracasso F; Tiné M; Saetta M; Maher TM; Balestro E
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.
    Huang Y; Ma SF; Espindola MS; Vij R; Oldham JM; Huffnagle GB; Erb-Downward JR; Flaherty KR; Moore BB; White ES; Zhou T; Li J; Lussier YA; Han MK; Kaminski N; Garcia JGN; Hogaboam CM; Martinez FJ; Noth I;
    Am J Respir Crit Care Med; 2017 Jul; 196(2):208-219. PubMed ID: 28157391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving role of the lung microbiome in pulmonary fibrosis.
    Lipinski JH; Moore BB; O'Dwyer DN
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L675-L682. PubMed ID: 32877221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.
    Kitsios GD; Rojas M; Kass DJ; Fitch A; Sembrat JC; Qin S; Veraldi KL; Gibson KF; Lindell K; Pilewski JM; Methe B; Li K; McDyer J; McVerry BJ; Morris A
    Thorax; 2018 May; 73(5):481-484. PubMed ID: 28802277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients.
    Tong X; Su F; Xu X; Xu H; Yang T; Xu Q; Dai H; Huang K; Zou L; Zhang W; Pei S; Xiao F; Li Y; Wang C
    Front Cell Infect Microbiol; 2019; 9():149. PubMed ID: 31165050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease.
    O'Dwyer DN; Kim JS; Ma SF; Ranjan P; Das P; Lipinski JH; Metcalf JD; Falkowski NR; Yow E; Anstrom K; Dickson RP; Huang Y; Gilbert JA; Martinez FJ; Noth I
    Am J Respir Crit Care Med; 2024 May; 209(9):1101-1110. PubMed ID: 38051927
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic expression of HOPX in alveolar epithelial cells reflects injury and repair during the progression of pulmonary fibrosis.
    Ota C; Ng-Blichfeldt JP; Korfei M; Alsafadi HN; Lehmann M; Skronska-Wasek W; M De Santis M; Guenther A; Wagner DE; Königshoff M
    Sci Rep; 2018 Aug; 8(1):12983. PubMed ID: 30154568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.